BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1183 related articles for article (PubMed ID: 27531099)

  • 1. SiNVICT: ultra-sensitive detection of single nucleotide variants and indels in circulating tumour DNA.
    Kockan C; Hach F; Sarrafi I; Bell RH; McConeghy B; Beja K; Haegert A; Wyatt AW; Volik SV; Chi KN; Collins CC; Sahinalp SC
    Bioinformatics; 2017 Jan; 33(1):26-34. PubMed ID: 27531099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural variation and fusion detection using targeted sequencing data from circulating cell free DNA.
    Gawroński AR; Lin YY; McConeghy B; LeBihan S; Asghari H; Koçkan C; Orabi B; Adra N; Pili R; Collins CC; Sahinalp SC; Hach F
    Nucleic Acids Res; 2019 Apr; 47(7):e38. PubMed ID: 30759232
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ultra-Sensitive Mutation Detection and Genome-Wide DNA Copy Number Reconstruction by Error-Corrected Circulating Tumor DNA Sequencing.
    Mansukhani S; Barber LJ; Kleftogiannis D; Moorcraft SY; Davidson M; Woolston A; Proszek PZ; Griffiths B; Fenwick K; Herman B; Matthews N; O'Leary B; Hulkki S; Gonzalez De Castro D; Patel A; Wotherspoon A; Okachi A; Rana I; Begum R; Davies MN; Powles T; von Loga K; Hubank M; Turner N; Watkins D; Chau I; Cunningham D; Lise S; Starling N; Gerlinger M
    Clin Chem; 2018 Nov; 64(11):1626-1635. PubMed ID: 30150316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detailed simulation of cancer exome sequencing data reveals differences and common limitations of variant callers.
    Hofmann AL; Behr J; Singer J; Kuipers J; Beisel C; Schraml P; Moch H; Beerenwinkel N
    BMC Bioinformatics; 2017 Jan; 18(1):8. PubMed ID: 28049408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ABEMUS: platform-specific and data-informed detection of somatic SNVs in cfDNA.
    Casiraghi N; Orlando F; Ciani Y; Xiang J; Sboner A; Elemento O; Attard G; Beltran H; Demichelis F; Romanel A
    Bioinformatics; 2020 May; 36(9):2665-2674. PubMed ID: 31922552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective blinded study of somatic mutation detection in cell-free DNA utilizing a targeted 54-gene next generation sequencing panel in metastatic solid tumor patients.
    Kim ST; Lee WS; Lanman RB; Mortimer S; Zill OA; Kim KM; Jang KT; Kim SH; Park SH; Park JO; Park YS; Lim HY; Eltoukhy H; Kang WK; Lee WY; Kim HC; Park K; Lee J; Talasaz A
    Oncotarget; 2015 Nov; 6(37):40360-9. PubMed ID: 26452027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy and reproducibility of somatic point mutation calling in clinical-type targeted sequencing data.
    Karimnezhad A; Palidwor GA; Thavorn K; Stewart DJ; Campbell PA; Lo B; Perkins TJ
    BMC Med Genomics; 2020 Oct; 13(1):156. PubMed ID: 33059707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of somatic variant detection algorithms using Ion Torrent targeted deep sequencing data.
    Wang Q; Kotoula V; Hsu PC; Papadopoulou K; Ho JWK; Fountzilas G; Giannoulatou E
    BMC Med Genomics; 2019 Dec; 12(Suppl 9):181. PubMed ID: 31874647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SECEDO: SNV-based subclone detection using ultra-low coverage single-cell DNA sequencing.
    Rozhoňová H; Danciu D; Stark S; Rätsch G; Kahles A; Lehmann KV
    Bioinformatics; 2022 Sep; 38(18):4293-4300. PubMed ID: 35900151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy of analysis of cfDNA for detection of single nucleotide variants and copy number variants in breast cancer.
    Yang X; Zhang K; Zhang C; Peng R; Sun C
    BMC Cancer; 2019 May; 19(1):465. PubMed ID: 31101027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of detecting indels in bacterial genomes from short-read sequencing data.
    Steglich M; Nübel U
    J Biotechnol; 2017 May; 250():11-15. PubMed ID: 28267569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Leveraging known genomic variants to improve detection of variants, especially close-by Indels.
    Vo NS; Phan V
    Bioinformatics; 2018 Sep; 34(17):2918-2926. PubMed ID: 29590294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care.
    Thierry AR
    Methods Mol Biol; 2016; 1392():1-16. PubMed ID: 26843041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNER: a novel background error suppression method for mutation detection in circulating tumor DNA.
    Deng S; Lira M; Huang D; Wang K; Valdez C; Kinong J; Rejto PA; Bienkowska J; Hardwick J; Xie T
    BMC Bioinformatics; 2018 Oct; 19(1):387. PubMed ID: 30342468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cell-Free Tumor DNA Analysis of 50 Genes by Next-Generation Sequencing in the Prospective MOSCATO Trial.
    Jovelet C; Ileana E; Le Deley MC; Motté N; Rosellini S; Romero A; Lefebvre C; Pedrero M; Pata-Merci N; Droin N; Deloger M; Massard C; Hollebecque A; Ferté C; Boichard A; Postel-Vinay S; Ngo-Camus M; De Baere T; Vielh P; Scoazec JY; Vassal G; Eggermont A; André F; Soria JC; Lacroix L
    Clin Cancer Res; 2016 Jun; 22(12):2960-8. PubMed ID: 26758560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical modeling for sensitive detection of low-frequency single nucleotide variants.
    Hao Y; Zhang P; Xuei X; Nakshatri H; Edenberg HJ; Li L; Liu Y
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):514. PubMed ID: 27556804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SNVSniffer: an integrated caller for germline and somatic single-nucleotide and indel mutations.
    Liu Y; Loewer M; Aluru S; Schmidt B
    BMC Syst Biol; 2016 Aug; 10 Suppl 2(Suppl 2):47. PubMed ID: 27489955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic variations in plasma cell free DNA differentiate early stage lung cancers from normal controls.
    Xia S; Huang CC; Le M; Dittmar R; Du M; Yuan T; Guo Y; Wang Y; Wang X; Tsai S; Suster S; Mackinnon AC; Wang L
    Lung Cancer; 2015 Oct; 90(1):78-84. PubMed ID: 26233568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole genome deep sequencing analysis of cell-free DNA in samples with low tumour content.
    Ganesamoorthy D; Robertson AJ; Chen W; Hall MB; Cao MD; Ferguson K; Lakhani SR; Nones K; Simpson PT; Coin LJM
    BMC Cancer; 2022 Jan; 22(1):85. PubMed ID: 35057759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating tumour DNA sequencing to determine therapeutic response and identify tumour heterogeneity in patients with paediatric solid tumours.
    Stankunaite R; George SL; Gallagher L; Jamal S; Shaikh R; Yuan L; Hughes D; Proszek PZ; Carter P; Pietka G; Heide T; James C; Tari H; Lynn C; Jain N; Portela LR; Rogers T; Vaidya SJ; Chisholm JC; Carceller F; Szychot E; Mandeville H; Angelini P; Jesudason AB; Jackson M; Marshall LV; Gatz SA; Anderson J; Sottoriva A; Chesler L; Hubank M
    Eur J Cancer; 2022 Feb; 162():209-220. PubMed ID: 34933802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.